Lipids at the interface of virus-host interactions

Current Opinion in Microbiology

Volumn 15, Issue 4, 2012, Pages 512-518

  Chukkapalli, Vineela ^a   Heaton, Nicholas S ^a   Randall, Glenn ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CERAMIDE; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAT DROPLET; FATTY ACID; ISOPRENOID; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPID; PROTEIN KINASE B; SPHINGOMYELIN; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; VERY LOW DENSITY LIPOPROTEIN; VIRUS RNA;

ADENOVIRUS; AUTOPHAGY; AVIAN ORTHOREOVIRUS; BIOSYNTHESIS; CYTOMEGALOVIRUS; DENGUE VIRUS; ENTEROVIRUS; FATTY ACID SYNTHESIS; FLAVIVIRUS; HEPATITIS C VIRUS; HERPES VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS A; INNATE IMMUNITY; KOBUVIRUS; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MOSAIC VIRUS; NONHUMAN; PICORNAVIRUS; REVIEW; RIFT VALLEY FEVER BUNYAVIRUS; RNA VIRUS; SIMIAN VIRUS 40; SINDBIS VIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS CELL INTERACTION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL MEMBRANE; DNA VIRUS INFECTIONS; DNA VIRUSES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LIPID METABOLISM; RNA VIRUS INFECTIONS; RNA VIRUSES; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84865301815     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2012.05.013     Document Type: Review

References (74)

1. den Boon J.A., Diaz A., Ahlquist P. Cytoplasmic viral replication complexes. Cell Host Microbe 2010, 8:77-85.
2. Carette J.E., Stuiver M., Van Lent J., Wellink J., Van Kammen A. Cowpea mosaic virus infection induces a massive proliferation of endoplasmic reticulum but not Golgi membranes and is dependent on de novo membrane synthesis. J Virol 2000, 74:6556-6563.
3. Guinea R., Carrasco L. Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J 1990, 9:2011-2016.
4. Cherry S., Kunte A., Wang H., Coyne C., Rawson R.B., Perrimon N. COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog 2006, 2:e102.
5. Sharma M., Sasvari Z., Nagy P.D. Inhibition of sterol biosynthesis reduces tombusvirus replication in yeast and plants. J Virol 2010, 84:2270-2281.
6. Sharma M., Sasvari Z., Nagy P.D. Inhibition of phospholipid biosynthesis decreases the activity of the tombusvirus replicase and alters the subcellular localization of replication proteins. Virology 2011, 415:141-152.
7. Perez L., Guinea R., Carrasco L. Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis. Virology 1991, 183:74-82.
8. Lee W.M., Ishikawa M., Ahlquist P. Mutation of host delta9 fatty acid desaturase inhibits brome mosaic virus RNA replication between template recognition and RNA synthesis. J Virol 2001, 75:2097-2106.
9. Zhang J., Diaz A., Mao L., Ahlquist P., Wang X. Host acyl-CoA binding protein regulates replication complex assembly and activity of a positive-strand RNA virus. J Virol 2012, 86:5110-5121.
10. Diaz A., Wang X., Ahlquist P. Membrane-shaping host reticulon proteins play crucial roles in viral RNA replication compartment formation and function. Proc Natl Acad Sci U S A 2010, 107:16291-16296.
11. Mackenzie J.M., Khromykh A.A., Parton R.G. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2007, 2:229-239.
12. Rothwell C., Lebreton A., Young Ng C., Lim J.Y., Liu W., Vasudevan S., Labow M., Gu F., Gaither L.A. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 2009, 389:8-19.
13. Poh M.K., Shui G., Xie X., Shi P.Y., Wenk M.R., Gu F. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res 2012, 93:191-198.
14. Heaton N.S., Perera R., Berger K.L., Khadka S., Lacount D.J., Kuhn R.J., Randall G. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A 2010, 107:17345-17350.
15. Perera R., Riley C., Isaac G., Hopf-Jannasch A.S., Moore R.J., Weitz K.W., Pasa-Tolic L., Metz T.O., Adamec J., Kuhn R.J. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog 2012, 8:e1002584.
16. Martin-Acebes M.A., Blazquez A.B., Jimenez de Oya N., Escribano-Romero E., Saiz J.C. West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One 2011, 6:e24970.
17. Yu G.Y., Lee K.J., Gao L., Lai M.M. Palmitoylation and polymerization of hepatitis C virus NS4B protein. J Virol 2006, 80:6013-6023.
18. Majeau N., Fromentin R., Savard C., Duval M., Tremblay M.J., Leclerc D. Palmitoylation of hepatitis C virus core protein is important for virion production. J Biol Chem 2009, 284:33915-33925.
19. Spencer C.M., Schafer X.L., Moorman N.J., Munger J. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 2011, 85:5814-5824.
20. Welsch S., Miller S., Romero-Brey I., Merz A., Bleck C.K., Walther P., Fuller S.D., Antony C., Krijnse-Locker J., Bartenschlager R. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 2009, 5:365-375.
21. Gillespie L.K., Hoenen A., Morgan G., Mackenzie J.M. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol 2010, 84:10438-10447.
22. Berger K.L., Kelly S.M., Jordan T.X., Tartell M.A., Randall G. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J Virol 2011, 85:8870-8883.
23. Reiss S., Rebhan I., Backes P., Romero-Brey I., Erfle H., Matula P., Kaderali L., Poenisch M., Blankenburg H., Hiet M.S., et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011, 9:32-45.
24. Tai A.W., Salloum S. The role of the phosphatidylinositol 4-kinase PI4KA in hepatitis C virus-induced host membrane rearrangement. PLoS One 2011, 6:e26300.
25. Berger K.L., Cooper J.D., Heaton N.S., Yoon R., Oakland T.E., Jordan T.X., Mateu G., Grakoui A., Randall G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci U S A 2009, 106:7577-7582.
26. Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010, 141:799-811.
27. Sasaki J., Ishikawa K., Arita M., Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J 2012, 31:754-766.
28. D'Angelo G., Vicinanza M., Di Campli A., De Matteis M.A. The multiple roles of PtdIns(4)P-not just the precursor of PtdIns(4,5)P2. J Cell Sci 2008, 121:1955-1963.
29. Amako Y., Sarkeshik A., Hotta H., Yates J., Siddiqui A. Role of oxysterol binding protein in hepatitis C virus infection. J Virol 2009, 83:9237-9246.
30. Amako Y., Syed G.H., Siddiqui A. Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J Biol Chem 2011, 286:11265-11274.
31. Tai A.W., Benita Y., Peng L.F., Kim S.S., Sakamoto N., Xavier R.J., Chung R.T. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009, 5:298-307.
32. Moorhead A.M., Jung J.Y., Smirnov A., Kaufer S., Scidmore M.A. Multiple host proteins that function in phosphatidylinositol-4-phosphate metabolism are recruited to the chlamydial inclusion. Infect Immun 2010, 78:1990-2007.
33. Weber S.S., Ragaz C., Reus K., Nyfeler Y., Hilbi H. Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog 2006, 2:e46.
34. Fernandis A.Z., Wenk M.R. Membrane lipids as signaling molecules. Curr Opin Lipidol 2007, 18:121-128.
35. Lorizate M., Krausslich H.G. Role of lipids in virus replication. Cold Spring Harb Perspect Biol 2011, 3:a004820.
36. Delgado T., Carroll P.A., Punjabi A.S., Margineantu D., Hockenbery D.M., Lagunoff M. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci U S A 2010, 107:10696-10701.
37. Munger J., Bajad S.U., Coller H.A., Shenk T., Rabinowitz J.D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2006, 2:e132.
38. Sanchez V., Dong J.J. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology 2010, 404:71-77.
39. Munger J., Bennett B.D., Parikh A., Feng X.J., McArdle J., Rabitz H.A., Shenk T., Rabinowitz J.D. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 2008, 26:1179-1186.
40. Herker E., Ott M. Emerging role of lipid droplets in host/pathogen interactions. J Biol Chem 2012, 287:2280-2287.
41. Brasaemle D.L., Wolins N.E. Packaging of fat: an evolving model of lipid droplet assembly and expansion. J Biol Chem 2012, 287:2273-2279.
42. Bartenschlager R., Penin F., Lohmann V., Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011, 19:95-103.
43. Herker E., Harris C., Hernandez C., Carpentier A., Kaehlcke K., Rosenberg A.R., Farese R.V., Ott M. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 2010, 16:1295-1298.
44. Alvisi G., Madan V., Bartenschlager R. Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol 2011, 8:258-269.
45. Piodi A., Chouteau P., Lerat H., Hezode C., Pawlotsky J.M. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Hepatology 2008, 48:16-27.
46. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A.M., Czaja M.J. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
47. Heaton N.S., Randall G. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 2010, 8:422-432.
48. Blackham S., Baillie A., Al-Hababi F., Remlinger K., You S., Hamatake R., McGarvey M.J. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol 2010, 84:5404-5414.
49. Diamond D.L., Syder A.J., Jacobs J.M., Sorensen C.M., Walters K.A., Proll S.C., McDermott J.E., Gritsenko M.A., Zhang Q., Zhao R., et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog 2010, 6:e1000719.
50. Rasmussen A.L., Diamond D.L., McDermott J.E., Gao X., Metz T.O., Matzke M.M., Carter V.S., Belisle S.E., Korth M.J., Waters K.M., et al. Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis. J Virol 2011, 85:11646-11654.
51. Ando T., Imamura H., Suzuki R., Aizaki H., Watanabe T., Wakita T., Suzuki T. Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog 2012, 8:e1002561.
52. Seo J.Y., Yaneva R., Hinson E.R., Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011, 332:1093-1097.
53. Wang Z.Q., Yu Y., Zhang X.H., Floyd E.Z., Cefalu W.T. Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting Cidec/FSP27 expression. Int J Obes (Lond) 2010, 34:1355-1364.
54. Kumar Y., Cocchiaro J., Valdivia R.H. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 2006, 16:1646-1651.
55. Cocchiaro J.L., Kumar Y., Fischer E.R., Hackstadt T., Valdivia R.H. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 2008, 105:9379-9384.
56. Daniel J., Maamar H., Deb C., Sirakova T.D., Kolattukudy P.E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 2011, 7:e1002093.
57. Mattos K.A., Lara F.A., Oliveira V.G., Rodrigues L.S., D'Avila H., Melo R.C., Manso P.P., Sarno E.N., Bozza P.T., Pessolani M.C. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell Microbiol 2011, 13:259-273.
58. Lazarow P.B. Viruses exploiting peroxisomes. Curr Opin Microbiol 2011, 14:458-469.
59. Moser T.S., Schieffer D., Cherry S. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog 2012, 8:e1002661.
60. Mankouri J., Harris M. Viruses and the fuel sensor: the emerging link between AMPK and virus replication. Rev Med Virol 2011, 21:205-212.
61. Mankouri J., Tedbury P.R., Gretton S., Hughes M.E., Griffin S.D., Dallas M.L., Green K.A., Hardie D.G., Peers C., Harris M. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proc Natl Acad Sci U S A 2010, 107:11549-11554.
62. Zhang H.S., Wu M.R. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. Virus Res 2009, 146:51-57.
63. Kumar S.H., Rangarajan A. Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol 2009, 83:8565-8574.
64. Ji W.T., Lee L.H., Lin F.L., Wang L., Liu H.J. AMP-activated protein kinase facilitates avian reovirus to induce mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 3/6 signalling that is beneficial for virus replication. J Gen Virol 2009, 90:3002-3009.
65. Moser T.S., Jones R.G., Thompson C.B., Coyne C.B., Cherry S. A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics. PLoS Pathog 2010, 6:e1000954.
66. Terry L.J., Vastag L., Rabinowitz J.D., Shenk T. Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. Proc Natl Acad Sci U S A 2012, 109:3071-3076.
67. McArdle J., Moorman N.J., Munger J. HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog 2012, 8:e1002502.
68. Blanc M., Hsieh W.Y., Robertson K.A., Watterson S., Shui G., Lacaze P., Khondoker M., Dickinson P., Sing G., Rodriguez-Martin S., et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 2011, 9:e1000598.
69. Wang X., Hinson E.R., Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2:96-105.
70. Heaton N.S., Randall G. Multifaceted roles for lipids in viral infection. Trends Microbiol 2011, 19:368-375.
71. Li Y., Webster-Cyriaque J., Tomlinson C.C., Yohe M., Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol 2004, 78:4197-4206.
72. Yang W., Hood B.L., Chadwick S.L., Liu S., Watkins S.C., Luo G., Conrads T.P., Wang T. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 2008, 48:1396-1403.
73. Arita M., Kojima H., Nagano T., Okabe T., Wakita T., Shimizu H. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol 2011, 85:2364-2372.
74. Bianco A., Reghellin V., Donnici L., Fenu S., Alvarez R., Baruffa C., Peri F., Pagani M., Abrignani S., Neddermann P., et al. Metabolism of phosphatidylinositol 4-kinase IIIalpha-dependent PI4P is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog 2012, 8:e1002576.